Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury

• DOI: 10.1038/srep23472
• Publication Date: 2016-03-24T10:13:04Z
• Authors: Se-Yeon Lee; Seahyoung Lee; Eunhyun Choi; Onju Ham; Chang Youn Lee; Jiyun Lee; Hyang-Hee Seo; Min-Ji Cha; Bohyun Mun; Yunmi Lee; Cheesoon Yoon; Ki-Chul Hwang
• Keywords: Male; 0301 basic medicine; Indoles; Cell Death; Myocardial Ischemia; Membrane Proteins; Benzazepines; Article; Rats; Up-Regulation; 3. Good health; Mitochondrial Proteins; Small Molecule Libraries; Disease Models, Animal; MicroRNAs; 03 medical and health sciences; Heart Function Tests; Animals; Myocytes, Cardiac; Cells, Cultured

AbstractGenetic ablation of BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3), an essential regulator of cardiac cell death, is an effective way to prevent cardiac cell death triggered by pathologic conditions. However, currently there exists no known means, such as inhibitors, to down-regulate BNIP3 in mature heart. Here, we report that a small molecule inducer of microRNA-182 (miR-182) suppressed ischemia/reperfusion (I/R)-induced cardiac cell death by down-regulating BNIP3. We first selected miR-182 as a potent BNIP3-targeting miRNA based on miRNA-target prediction databases and empirical data. The subsequent screening of small molecules for inducing miR-182 expression identified Kenpaullone as a hit compound. Both exogenous miR-182 and Kenpaullone significantly suppressed hypoxia-induced cardiomyocyte death in vitro. To investigate the effect of changing substituents of Kenpaullone on miR-182 expression, we synthesized 9 derivatives of Kenpaullone. Among these derivatives, compound 5 showed significantly improved ability to induce miR-182 expression. The results of the in vivo study showed that compound 5 significantly improved heart function following I/R-injury in rats. Our study provides strong evidence that the small molecule-mediated up-regulation of miRNAs is a viable strategy to down-regulate target proteins with no known chemical inhibitor and that compound 5 may have potential to prevent I/R-inflicted cardiac cell death.